Mufaso
10 minutes ago
Interesting comments by the Novartis CEO Vas Narasimhan on obesity market.
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says:
“With obesity right now, we have two very entrenched large players, and I think for future entrants you have to find something new, som